Nintedanib plus sildenafil versus nintedanib alone in patients with IPF and severely impaired gas exchange: subgroup analysis by right heart dysfunction*

J Behr; M Kolb; JW Song; F Luppi; B Schinzel; S Stowasser; M Quaresma; FJ Martinez

doi:10.1055/s-0039-3403295

Pneumologie, Table of Contents

Pneumologie 2020; 74(S 01): 105
DOI: 10.1055/s-0039-3403295

Posterbegehung (PO20) – Sektion Klinische Pneumologie

Fortschritte bei Lungenfibrosen 2020

Georg Thieme Verlag KG Stuttgart · New York

Nintedanib plus sildenafil versus nintedanib alone in patients with IPF and severely impaired gas exchange: subgroup analysis by right heart dysfunction*

J Behr

¹Medizinische Klinik und Poliklinik V, University of Munich, LMU and Asklepios Klinik München-Gauting, Member of the German Center for Lung Research, Germany

,

M Kolb

²Mcmaster University and St. Josephʼs Healthcare, Hamilton, Ontario, Canada

,

JW Song

³Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea

,

F Luppi

⁴University Hospital of Modena, Modena, Italy

,

B Schinzel

⁵Boehringer Ingelheim International GmbH, Ingelheim, Germany

,

S Stowasser

⁵Boehringer Ingelheim International GmbH, Ingelheim, Germany

,

M Quaresma

⁵Boehringer Ingelheim International GmbH, Ingelheim, Germany

,

FJ Martinez

⁶Weill Cornell Medicine, New York, USA

› Author Affiliations